CytoViva
CytoViva’s technology combines patented, enhanced darkfield optical microscopy with high resolution hyperspectral imaging. These integrated technologies were specifically designed to enable optical observation and spectral characterization of label free nano-materials as they interact with biological and other materials-based matrixes.
Introduced in 2005, CytoViva technology has been installed in hundreds of research laboratories. This includes leading national research laboratories, academic institutes and private industrial labs across the Americas, Asia and Europe.
Co-developed by Auburn University and Aetos Technologies, Inc., CytoViva’s optical microscopy technology is a 2006 and 2007 recipient of the prestigious R&D 100 award. This award is granted annually to the market’s most innovative new technologies. In 2007, CytoViva also received a Nano50TM award, for its contribution to the fast growing world of nanotechnology research. In 2009, US patents No. 7,542,203 and 7,564,623 were issued for CytoViva’s advanced microscopy illumination optics.
The CytoViva Hyperspectral Imaging System evolved from technology originally developed for aerial based imaging applications within Department of Defense and NASA. CytoViva has adapted this technology to operate as a proprietary, integrated system with its patented microscopy technology, enabling spectral quantification of materials and live biologicals at the nanoscale.
CytoViva300 North Dean Road |
Share with friends:
Next companies in category
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2024 Nanotechnology research | All rights reserved | Developed by Makovic.net